1. Coles, G.G. Rhodes, A.C. Stafford, K.A., (2000) Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Veterinary Record 146, 504.
Fasinex™ 5% Oral Suspension contains 5% w/v triclabendazole. Fasinex™ 240 Oral Suspension for cattle contains 24% w/v triclabendazole. Combinex™ Oral Suspension contains 3.75% w/v levamisole hydrochloride and 5% w/v triclabendazole. Fasimec™ Duo 50 mg/ml + 1 mg/ml Oral Suspension for Sheep contains 50 mg/ml triclabendazole and 1 mg/ml ivermectin. Flukiver™ 5% w/v oral Suspension contains 50mg/ml closantel. Supaverm™ Oral Suspension contains 5% w/v closantel and 7.5% w/v mebendazole. Rycoben™ SC for Sheep contains 2.5% w/v albendazole oxide (ricobendazole), 1.8% w/v cobalt sulphate and 0.097% w/v sodium selenate.
Legal category: POM-VPS
Information regarding the side effects, precautions, warnings and contra-indications can be found in product packaging and leaflets; further information can also be found in the Summary of Product Characteristics.
Elanco™, Combinex™, Fasimec™ Duo, Fasinex™, Flukiver™, Supaverm™ and Rycoben™ are trademarks of Elanco or its affiliates.
Use Medicines Responsibly (www.noah.co.uk/responsible) Advice should be sought from the prescriber prior to use.